These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6111725)

  • 1. The hypotheses of different dopamine receptor mechanisms.
    Costall B; Naylor RJ
    Life Sci; 1981 Jan; 28(3):215-29. PubMed ID: 6111725
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 3. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular dopamine receptor as a model for other dopamine receptors.
    Goldberg LI
    Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
    [No Abstract]   [Full Text] [Related]  

  • 5. beta-Adrenergic receptor-sensitive adenosine cyclic 3',5'-monophosphate accumulation in homogenates of the rat corpus striatum. A comparison with the dopamine receptor-coupled adenylate cyclase.
    Harris JE
    Biochem Pharmacol; 1978; 27(24):2919-25. PubMed ID: 216372
    [No Abstract]   [Full Text] [Related]  

  • 6. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
    Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple receptors for dopamine.
    Kebabian JW; Calne DB
    Nature; 1979 Jan; 277(5692):93-6. PubMed ID: 215920
    [No Abstract]   [Full Text] [Related]  

  • 8. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 59(3):211-6. PubMed ID: 32570
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent.
    Barone D; Corsico N; Diena A; Restelli A; Glässer A; Rodenghi F
    J Pharm Pharmacol; 1982 Feb; 34(2):129-32. PubMed ID: 6121878
    [No Abstract]   [Full Text] [Related]  

  • 11. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-dependent regulator involvement in the dopamine receptors supersensitivity.
    Lucchelli A
    Pharmacol Res Commun; 1980 Jul; 12(7):709-17. PubMed ID: 7190711
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
    Jenner P; Elliott PN; Clow A; Reavill C; Marsden CD
    J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.
    Arnt J; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1982 Dec; 86(2):185-98. PubMed ID: 6130958
    [No Abstract]   [Full Text] [Related]  

  • 18. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
    Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M
    Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine receptor sensitivity after repeated morphine administrations to rats.
    Kuschinsky K
    Life Sci; 1975 Jul; 17(1):43-8. PubMed ID: 167254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.